Q1 2023 Holdings
Filed 2023-05-15 | 24 holdings | $391.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $127.0M | 5,798,475 | 32.5% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $63.9M | 4,408,379 | 16.3% |
| VOR Biopharma Inc | COM | 929033108 | $34.2M | 6,361,723 | 8.8% |
| Rallybio Corp | COM | 75120L100 | $20.7M | 3,630,724 | 5.3% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $13.8M | 862,286 | 3.5% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $12.5M | 588,442 | 3.2% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $11.9M | 868,520 | 3.0% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $10.9M | 1,200,647 | 2.8% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $10.8M | 579,434 | 2.8% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $10.2M | 665,555 | 2.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $8.7M | 320,000 | 2.2% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $8.5M | 790,440 | 2.2% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $7.8M | 357,733 | 2.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $7.1M | 280,000 | 1.8% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $6.9M | 284,626 | 1.8% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $5.8M | 350,000 | 1.5% |
| Spruce Biosciences Inc | COM | 85209E109 | $5.2M | 2,364,000 | 1.3% |
| Mersana Therapeutics Inc | COM | 59045L106 | $4.9M | 1,185,000 | 1.2% |
| Pharvaris N V(PHVS) | COM | N69605108 | $4.7M | 587,600 | 1.2% |
| Homology Medicines Inc | COM | 438083107 | $4.7M | 4,535,919 | 1.2% |
| Pear Therapeutics Inc | CLASS A COM | 704723105 | $4.3M | 16,744,113 | 1.1% |
| Impel Pharmaceuticals Inc | COM | 45258K109 | $4.0M | 2,884,791 | 1.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $1.4M | 1,134,511 | 0.4% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $831.1K | 38,856 | 0.2% |